FilingSEC EDGAR8-K
Matinas BioPharma Receives NYSE American Non-Compliance Notice
· SEC accepted
StageListing Warning
Filing content
Matinas BioPharma received a notice from NYSE American regarding non-compliance with the $2.0 million stockholders' equity requirement for continued listing.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…